Description
Class: Synthetic triple-receptor agonist (GLP-1 / GIP / glucagon).
Mechanism: Binds and activates glucagon-like peptide-1, glucose-dependent insulinotropic polypeptide, and glucagon receptors. Published literature reports effects on insulin secretion, gastric motility, and hepatic energy expenditure in study models.
Specification: Lyophilized powder, ≥99% purity. Requires reconstitution. Supplied as 10 vials of 30 mg.
Storage: Store lyophilized at −20°C. Protect from light.
For laboratory research use only. Not for human or veterinary use. Not a drug, food, or cosmetic. These statements have not been evaluated by the US Food and Drug Administration.





